NDC 68788-8329 – Benzonatate
Benzonatate 200 mg/1 · Capsule · Oral
Product NDC68788-8329
Product details
- Brand name
- Benzonatate
- Generic name
- Benzonatate
- Labeler
- Preferred Pharmaceuticals Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA206948
- Marketed since
- January 20, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Non-narcotic Antitussive
Active ingredients
- Benzonatate 200 mg/1
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 68788-8329-1 | 15 CAPSULE in 1 BOTTLE (68788-8329-1) | Jan 20, 2023 |
| 68788-8329-2 | 20 CAPSULE in 1 BOTTLE (68788-8329-2) | Jan 20, 2023 |
| 68788-8329-3 | 30 CAPSULE in 1 BOTTLE (68788-8329-3) | Jan 20, 2023 |
| 68788-8329-6 | 60 CAPSULE in 1 BOTTLE (68788-8329-6) | Jan 20, 2023 |
Other Benzonatate products
- 50090-6080 Benzonatate 200 mg/1 · Capsule · A-S Medication Solutions
- 50090-6294 Benzonatate 200 mg/1 · Capsule · A-S Medication Solutions
- 50090-6850 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-6387 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-4968 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-4969 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-5409 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-5986 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 68084-214 Benzonatate 100 mg/1 · Capsule · American Health Packaging
- 87519-111 Benzonatate 150 mg/1 · Capsule · Anvi Pharmaceuticals Inc
- 71610-692 Benzonatate 100 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC
- 67877-573 Benzonatate 100 mg/1 · Capsule · Ascend Laboratories, LLC